Anaplastic Thyroid Cancer Symptoms: A UK GP Guide to Red Flags, the NHS Two-Week Wait and Recent Treatment Advances

Anaplastic thyroid cancer is rare, with around 100 to 150 new UK cases each year per Cancer Research UK. Recognising a rapidly enlarging hard neck lump – particularly with voice change or difficulty swallowing – allows the NHS two-week wait pathway to act quickly.

You have searched for anaplastic thyroid cancer symptoms, probably because you or someone close to you has found a neck lump, had a change in voice, or come across the term in conversation with a clinician, in the news or on social media. That search is understandable, and the first thing to say is a straightforward reassurance: most thyroid lumps are not cancer at all. Anaplastic thyroid cancer specifically is a rare disease. Cancer Research UK records around 100 to 150 new cases each year across the whole UK population.

It is, however, an aggressive cancer when it does occur, and recognising the warning signs early matters because the NHS can move quickly when there is a clinical reason to escalate. This article is a calm, NHS-aligned UK guide to what the disease is, the specific symptom pattern that warrants urgent assessment, the two-week wait referral pathway, and the genuinely significant treatment advances that have changed survival figures for selected patients in the last three years.

What anaplastic thyroid cancer actually is – in plain UK English

Anaplastic thyroid cancer is the most aggressive of the four main types of thyroid cancer. The thyroid gland sits in the lower front of the neck, just below the Adam’s apple, and produces hormones that regulate metabolism. Most thyroid cancers are papillary or follicular. These are slow-growing, highly treatable and carry a five-year survival rate above 95 per cent. Medullary thyroid cancer arises from the calcitonin-producing C cells of the gland and can sometimes be inherited. Anaplastic thyroid cancer is in a different category altogether. It develops when thyroid cancer cells lose the features of normal thyroid tissue. This loss of differentiation is what makes the disease so fast-growing – visible week to week rather than year to year – and so difficult to treat. Around 1 to 2 per cent of all UK thyroid cancers are anaplastic. Cancer Research UK estimates 100 to 150 new cases each year nationally. The median age at diagnosis falls in the 65 to 75 bracket, and the disease is rare under the age of 60. Women are affected slightly more often than men, by roughly 1.5 to 1. In about a quarter of cases, anaplastic disease develops from a long-standing papillary or follicular cancer that has transformed over time. The remainder appear to arise as anaplastic from the start. None of this means that someone with a slow-growing or longstanding thyroid lump should expect this diagnosis. Anaplastic disease has a very distinctive clinical pattern, which the next section covers.

The red-flag symptom pattern – what to actually look for

The single most important warning sign of anaplastic thyroid cancer is a rapidly enlarging neck lump. Unlike papillary or follicular cancers, which often grow so slowly that patients notice no change over years, anaplastic disease typically presents as a lump in the lower front of the neck that visibly grows over days to weeks. It is usually painless at first, hard on examination, and often fixed – meaning it does not move freely when you swallow or push on it gently. Associated red-flag symptoms develop when the tumour begins to invade or compress the structures surrounding the thyroid gland. New or worsening hoarseness lasting more than three weeks can suggest involvement of the recurrent laryngeal nerve, which controls one of the vocal cords. Difficulty swallowing, particularly for solid food, may indicate pressure on or invasion of the oesophagus. Difficulty breathing or noisy breathing, sometimes called stridor, can mean the tumour is compressing the trachea. A persistent cough, occasionally with blood-streaked sputum, can develop if the airway is involved. Pain in the front of the neck or radiating up into the ear is common in more advanced disease. Swollen lymph nodes in the neck may also be felt. Systemic symptoms such as unintended weight loss, severe fatigue and general decline tend to appear in later stages. The combination that should prompt very rapid GP review is a hard lump in the lower neck that has appeared recently or grown noticeably, particularly when it is paired with voice change, difficulty swallowing or any change in breathing.

Most thyroid lumps are not cancer – what is more likely

Before going any further, a reassurance. Thyroid lumps are common. NICE clinical knowledge summary guidance for primary care notes that the majority of palpable thyroid nodules are benign. Benign thyroid nodules are very common, particularly in women and with increasing age. Many are picked up by chance on neck scans done for unrelated reasons. Simple thyroid cysts, which are fluid-filled sacs within the gland, are common and usually harmless. Multinodular goitre, a thyroid gland that has developed several nodules, is common in middle-aged adults and is mostly benign. Hashimoto’s thyroiditis, an autoimmune condition that causes inflammation of the thyroid, can produce an enlarged gland that feels firm to the touch. Graves’ disease and other forms of hyperthyroidism can also enlarge the gland. None of these conditions are cancer, though all should be evaluated by a GP if newly noticed. The features that make a lump less likely to be cancerous include a soft or rubbery texture, a lump that moves freely when you swallow, slow or no change over months or years, no associated voice change or swallowing difficulty, and normal results from blood tests for thyroid function. If your lump is small, has been stable for a long time, moves freely and is not associated with any voice or swallowing change, the probability of anaplastic thyroid cancer in particular is extremely low. The point of recognising red-flag symptoms is not to assume the worst. It is to make sure that the very small number of people who do have an aggressive cancer reach specialist care quickly.

The NHS two-week wait pathway – how the system actually works

Under NICE guideline NG12, Suspected cancer: recognition and referral, and NHS England two-week wait rules, any GP who suspects thyroid cancer must refer the patient to be seen by a specialist within 14 days. The triggers for an urgent suspected cancer referral are an unexplained thyroid lump, a rapidly enlarging painless thyroid mass over days or weeks, or a thyroid lump combined with a red flag such as voice change, difficulty swallowing or a hard fixed mass. The standard NHS pathway begins with the GP appointment. The GP takes a history, examines the neck and the thyroid, and arranges baseline blood tests including thyroid stimulating hormone and free T4. If medullary thyroid cancer is on the differential, the GP may also request a calcitonin level. The GP then completes a two-week wait referral letter to the local head and neck cancer or endocrine surgery service. Within 14 days, the patient is seen in clinic for a specialist examination, an ultrasound of the thyroid and the neck lymph nodes, and often a same-day fine-needle aspiration for cytology. CT scans of the neck and chest are arranged to assess local extent and to check for any spread. Where the fine-needle aspiration result raises concern for anaplastic disease, the pathway moves very quickly. Some UK centres are now able to confirm the diagnosis and start systemic therapy within 7 to 10 days of the first specialist appointment, because for this particular cancer every day matters. If the biopsy is benign, the patient is reassured and either discharged or followed up routinely.

Treatment in the UK in 2026 – what has actually changed

Anaplastic thyroid cancer was for decades a near-uniformly fatal diagnosis within months. That picture has started to change in a meaningful way. The single most important change in NHS care since 2022 has been routine commissioning of dabrafenib plus trametinib for the roughly 40 to 50 per cent of cases that carry a BRAF V600E mutation. NHS England now requires all confirmed anaplastic thyroid cancers to be reflex-tested for BRAF, RAS, RET and TERT mutations, because the result directly changes treatment within days. If BRAF V600E is present, oral dabrafenib plus trametinib is started immediately, often before a formal multidisciplinary team review has taken place. In NHS practice, the combination has produced durable responses in patients whose historical median survival was only 4 to 6 months. Data from MD Anderson Cancer Centre, frequently cited in NHS multidisciplinary team meetings, report median survival rising from around 7 months to approximately 28 months with this multimodal approach. Surgery is offered when complete removal of the tumour is feasible, which is uncommon at first presentation but has become increasingly possible after neoadjuvant targeted therapy in selected patients. External beam radiotherapy is used to slow local progression and to protect the airway. Lenvatinib, an oral multi-kinase inhibitor, is used in some patients. Pembrolizumab, an immune checkpoint inhibitor, is being added to dabrafenib and trametinib in trial settings and has produced very encouraging early survival data, with median overall survival reported at over 60 months in one recent series. Palliative care is integrated from the point of diagnosis, because even with all of this progress most patients with anaplastic thyroid cancer cannot yet be cured. Good palliative input is a sign of high-quality care, not a sign of giving up.

What to do if you are worried right now – a calm action plan

If you have noticed a new neck lump, the first step is to arrange a routine GP appointment within the next week or so. Phone the surgery. Describe what you have found in clear terms. Ask for a face-to-face appointment for a neck examination. Most practices will offer you one within a few days. If your lump is rapidly enlarging, meaning visibly bigger over a small number of days or weeks, or if you have noticed any voice change, difficulty swallowing or any change in your breathing, ask the receptionist to flag the appointment as urgent. Most NHS practices have a same-day or next-day appointment system for this kind of presentation. At the appointment, take a written list with you. Include when you first noticed the lump, how its size has changed, whether you have experienced any voice changes or difficulty swallowing, any breathing difficulty, any unintentional weight loss, and any family history of thyroid disease or other cancers. Ask the GP what they think the most likely cause is, what blood tests they are arranging, whether they are referring you for an ultrasound, and whether a two-week wait referral is needed. Most lumps will turn out to be benign and will not require a two-week wait referral. If a referral is made, the specialist team will take over the rest of the pathway. While you wait for your appointment, avoid smoking, keep alcohol intake modest, and continue normal daily activity. If you develop sudden breathing difficulty, severe pain or signs that your windpipe is being blocked, call 999 immediately.

Frequently Asked Questions

How rare is anaplastic thyroid cancer in the UK?

Very rare. Cancer Research UK records around 100 to 150 new cases each year across the whole UK population. That is approximately 1 to 2 per cent of all thyroid cancers. Most thyroid cancers diagnosed in the UK are papillary, which is slow-growing and highly treatable, with a five-year survival rate above 95 per cent. Anaplastic thyroid cancer is more common over the age of 65 and slightly more common in women than in men. Under the age of 60, it is genuinely uncommon.

What does anaplastic thyroid cancer feel like to touch?

The typical lump is hard rather than soft, painless at first, located in the lower front of the neck, and often fixed, meaning it does not move freely when you swallow or push on it gently. The single most important feature is rapid growth: visibly larger over days to weeks rather than months or years. A soft, mobile lump that has been stable in size for a long time is far more likely to be benign. Any rapidly growing thyroid lump warrants urgent GP review regardless of other features.

How quickly will the NHS see me if my GP suspects thyroid cancer?

Within 14 days. Under NICE NG12 and NHS England two-week wait rules, anyone with a suspected thyroid cancer must be seen by a specialist within two weeks of their GP making the referral. The first specialist appointment usually includes a neck examination, an ultrasound of the thyroid and neck lymph nodes, and often a same-day fine-needle aspiration. If the ultrasound or biopsy raises concern for anaplastic disease, some UK centres are now able to confirm the diagnosis and begin systemic therapy within 7 to 10 days.

What is dabrafenib plus trametinib and who gets it on the NHS?

Dabrafenib and trametinib are oral targeted therapies that block the BRAF and MEK proteins respectively. About 40 to 50 per cent of anaplastic thyroid cancers carry a BRAF V600E mutation, which makes them vulnerable to this drug combination. NHS England has commissioned dabrafenib plus trametinib for routine NHS use since 2022 for BRAF V600E mutated anaplastic thyroid cancer. All confirmed cases are now reflex-tested for the mutation. If the test is positive, treatment usually starts within days and has substantially extended survival in many patients.

Can anaplastic thyroid cancer be cured?

In most cases, no, but the outlook has improved considerably. Historically, median survival was 4 to 6 months and five-year survival was under 10 per cent. With modern multidisciplinary care including BRAF mutation testing, targeted therapy, radiotherapy and selected surgery, recent UK and US series report median survival rising to approximately 28 months in BRAF V600E mutated cases. Two-year survival above 60 per cent has been reported in some neoadjuvant cohorts. A small minority of selected patients now achieve long-term remission, which was almost unheard of a decade ago.

Are most thyroid lumps cancer?

No. The majority of thyroid lumps are benign. NICE clinical knowledge summary guidance for UK primary care notes that most palpable thyroid nodules are non-cancerous. Common benign causes include simple thyroid cysts, multinodular goitre, Hashimoto’s thyroiditis and Graves’ disease. Approximately 5 to 10 per cent of investigated thyroid lumps turn out to be cancer, and only a small fraction of those are the aggressive anaplastic form. Any newly noticed lump should still be examined by a GP for reassurance and proper assessment.

This article is informational only and does not replace personalised advice from your GP, pharmacist, or another qualified healthcare professional.